[go: up one dir, main page]

GB201819937D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201819937D0
GB201819937D0 GBGB1819937.2A GB201819937A GB201819937D0 GB 201819937 D0 GB201819937 D0 GB 201819937D0 GB 201819937 A GB201819937 A GB 201819937A GB 201819937 D0 GB201819937 D0 GB 201819937D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1819937.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Discovery Ltd
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Priority to GBGB1819937.2A priority Critical patent/GB201819937D0/en
Publication of GB201819937D0 publication Critical patent/GB201819937D0/en
Priority to SG11202105913RA priority patent/SG11202105913RA/en
Priority to CN201980090768.3A priority patent/CN113365696A/en
Priority to JP2021532111A priority patent/JP2022512128A/en
Priority to KR1020217020079A priority patent/KR20210102285A/en
Priority to EP19821176.5A priority patent/EP3890829A1/en
Priority to PCT/GB2019/053457 priority patent/WO2020115501A1/en
Priority to CA3121376A priority patent/CA3121376A1/en
Priority to MX2021006540A priority patent/MX2021006540A/en
Priority to BR112021010644-8A priority patent/BR112021010644A2/en
Priority to AU2019393162A priority patent/AU2019393162A1/en
Priority to US17/299,959 priority patent/US20220033397A1/en
Priority to IL283706A priority patent/IL283706A/en
Ceased legal-status Critical Current

Links

GBGB1819937.2A 2018-12-06 2018-12-06 Pharmaceutical compounds Ceased GB201819937D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1819937.2A GB201819937D0 (en) 2018-12-06 2018-12-06 Pharmaceutical compounds
US17/299,959 US20220033397A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
PCT/GB2019/053457 WO2020115501A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
CN201980090768.3A CN113365696A (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin-specific protease 19(USP19)
JP2021532111A JP2022512128A (en) 2018-12-06 2019-12-06 Its use as a pharmaceutical compound and ubiquitin-specific protease 19 (USP19) inhibitor
KR1020217020079A KR20210102285A (en) 2018-12-06 2019-12-06 Use as pharmaceutical compounds and inhibitors of ubiquitin-specific protease 19 (USP19)
EP19821176.5A EP3890829A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
SG11202105913RA SG11202105913RA (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
CA3121376A CA3121376A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
MX2021006540A MX2021006540A (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19).
BR112021010644-8A BR112021010644A2 (en) 2018-12-06 2019-12-06 COMPOUND, STEREOISOMER, TAUTOMER, HYDRATE, N-OXIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION, METHODS FOR TREATMENT OF OBESITY, INSULIN RESISTANCE, TYPE II DIABETES, MUSCLE ATROPHY AND CANCER AND FOR REDUCTION OF MUSCLE MASS LOSS IN AN INDIVIDUAL , AND, USP19 INHIBITOR
AU2019393162A AU2019393162A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of Ubiquitin Specific Protease 19 (USP19)
IL283706A IL283706A (en) 2018-12-06 2021-06-03 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1819937.2A GB201819937D0 (en) 2018-12-06 2018-12-06 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201819937D0 true GB201819937D0 (en) 2019-01-23

Family

ID=65029927

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1819937.2A Ceased GB201819937D0 (en) 2018-12-06 2018-12-06 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB201819937D0 (en)

Similar Documents

Publication Publication Date Title
IL276232A (en) Pharmaceutical compounds
GB201911928D0 (en) Pharmaceutical compounds
GB2572126B (en) Pharmaceutical
GB2569961B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
EP3638658C0 (en) Pharmaceutical compounds
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
GB201704714D0 (en) Pharmaceutical compounds
GB201911944D0 (en) Pharmaceutical compounds
GB201704965D0 (en) Pharmaceutical compounds
GB201703881D0 (en) Pharmaceutical compounds
GB201819960D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
GB201915932D0 (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
GB201706806D0 (en) Pharmaceutical compounds
GB201801562D0 (en) Pharmaceutical compounds
GB201711704D0 (en) Pharmaceutical compounds
LT3728220T (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
GB201704966D0 (en) Pharmaceutical compounds
IL291570A (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)